Jack Anders Revolution Medicines, Inc. (RVMD) insider trading activity

RVMD Quotes by TradingView

Jack Anders is Chief Financial Officer of Revolution Medicines, Inc.. Currently has a direct ownership of 96,470 shares of RVMD, which is worth approximately $4.25 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 2,635 shares (Common Stock) at a price of $45.4 per share, resulting in proceeds of $119,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.5K
2.49% 3M change
26.24% 12M change
Total Value Held $4.25 Million

Jack Anders Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2024
SELL
Open market or private sale
$119,629 $45.4 p/Share
2,635 Reduced 2.66%
96,470 Common Stock
Oct 11 2024
SELL
Open market or private sale
$503,000 $50.3 p/Share
10,000 Reduced 9.18%
98,932 Common Stock
Oct 11 2024
BUY
Exercise of conversion of derivative security
$26,800 $2.68 p/Share
10,000 Added 8.41%
108,932 Common Stock
Sep 16 2024
SELL
Open market or private sale
$99,162 $44.19 p/Share
2,244 Reduced 2.22%
98,932 Common Stock
Jun 17 2024
SELL
Open market or private sale
$70,779 $37.39 p/Share
1,893 Reduced 1.84%
101,176 Common Stock
May 03 2024
SELL
Open market or private sale
$400,300 $40.03 p/Share
10,000 Reduced 8.93%
101,959 Common Stock
May 03 2024
BUY
Exercise of conversion of derivative security
$26,800 $2.68 p/Share
10,000 Added 8.2%
111,959 Common Stock
Mar 18 2024
SELL
Open market or private sale
$39,822 $31.58 p/Share
1,261 Reduced 1.22%
101,959 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
26,400 Added 20.37%
103,220 Common Stock
Dec 18 2023
SELL
Open market or private sale
$45,972 $25.9 p/Share
1,775 Reduced 2.27%
76,416 Common Stock
Oct 23 2023
BUY
Exercise of conversion of derivative security
$83,136 $3.39 p/Share
24,524 Added 23.88%
78,191 Common Stock
Sep 18 2023
SELL
Open market or private sale
$44,679 $31.31 p/Share
1,427 Reduced 2.59%
53,667 Common Stock
Sep 01 2023
SELL
Open market or private sale
$701,000 $35.05 p/Share
20,000 Reduced 26.63%
55,094 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
$53,600 $2.68 p/Share
20,000 Added 21.03%
75,094 Common Stock
Jun 20 2023
SELL
Open market or private sale
$31,087 $24.89 p/Share
1,249 Reduced 2.22%
55,094 Common Stock
Mar 17 2023
SELL
Open market or private sale
$14,483 $21.78 p/Share
665 Reduced 1.19%
55,233 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
26,600 Added 32.24%
55,898 Common Stock
Dec 19 2022
SELL
Open market or private sale
$15,094 $22.94 p/Share
658 Reduced 2.2%
29,298 Common Stock
Sep 19 2022
SELL
Open market or private sale
$8,549 $19.04 p/Share
449 Reduced 1.48%
29,956 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 24.75%
30,405 Common Stock
Jun 17 2022
SELL
Open market or private sale
$7,206 $17.75 p/Share
406 Reduced 1.95%
20,405 Common Stock
Mar 17 2022
SELL
Open market or private sale
$2,961 $18.62 p/Share
159 Reduced 0.79%
19,875 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
11,600 Added 36.67%
20,034 Common Stock
Dec 17 2021
SELL
Open market or private sale
$4,150 $24.41 p/Share
170 Reduced 1.98%
8,434 Common Stock
Sep 17 2021
SELL
Open market or private sale
$4,983 $30.02 p/Share
166 Reduced 1.99%
8,192 Common Stock
JA

Jack Anders

Chief Financial Officer
Redwood City, CA

Track Institutional and Insider Activities on RVMD

Follow Revolution Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

News

Receive news related to Revolution Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVMD